SCHEMBL6535331

SCHEMBL6535331

CC(=O)[C@H](O)[C@@H](O)CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL619208 1.00
SCHEMBL13518411 1.00
SCHEMBL30854321 1.00
SCHEMBL9275294 1.00
SCHEMBL268213 1.00
SCHEMBL17590201 1.00
SCHEMBL14387629 1.00
Bicarbonate SCHEMBL3708811 0.95 PDE4A (0.46)
Phosphoric Acid SCHEMBL30182555 0.90 PDE4A (0.38)
Phosphoric Acid SCHEMBL29852280 0.90 PDE4A (0.38)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117903386-A Method for realizing liquid phase polymerization of high-concentration polyhydroxy aldehyde or (and) polyhydroxy ketone through liquid thereof under high-temperature condition 厦门碳控科技投资有限公司 2024-04-19 CN claimed
US-20240207209-A1 Threonate Compounds and Methods of Use Thereof NEUROCENTRIA, INC. 2024-06-27 US disclosed
CN-117903386-A Method for realizing liquid phase polymerization of high-concentration polyhydroxy aldehyde or (and) polyhydroxy ketone through liquid thereof under high-temperature condition 厦门碳控科技投资有限公司 2024-04-19 CN disclosed
US-20230355556-A1 Threonate Compounds and Methods of Use Thereof NEUROCENTRIA, INC. 2023-11-09 US disclosed
US-20170128397-A1 THREONATE COMPOUNDS AND METHODS OF USE THEREOF NEUROCENTRIA, INC. 2017-05-11 US disclosed
WO-2012072630-A1 PROCESS FOR PRODUCING FLAVOURS GIVAUDAN SA (CH) 2012-06-07 WO disclosed
WO-2012072631-A1 PROCESS FOR PRODUCING FLAVOURS GIVAUDAN SA (CH) 2012-06-07 WO disclosed
EP-1038018-A4 ALDOL CONDENSATIONS BY CATALYTIC ANTIBODIES SCRIPPS RESEARCH INST (US) 2004-10-13 EP disclosed
US-6589766-B1 Use to catalyze ketone-ketone, ketone-aldehyde, aldehyde-ketone, and aldehyde-aldehyde intermolecular aldol reactions, and in some cases to catalyze their subsequent dehydration to yield aldol condensation products THE SCRIPPS RESEARCH INSTITUTE 2003-07-08 US disclosed
US-20020142422-A1 Moss genes from physcomitrella patens encoding proteins involved in the synthesis of amino acids, vitamins, cofactors, nucleotides and nucleosides BASF PLANT SCIENCE GMBH (DE) 2002-10-03 US disclosed
US-6326176-B1 ALDOL CONDENSATIONS AND CATALYTIC ANTIBODIES THE SCRIPPS RESEARCH INSTITUTE 2001-12-04 US disclosed
EP-1038018-A1 ALDOL CONDENSATIONS BY CATALYTIC ANTIBODIES The Scripps Research Institute (US) 2000-09-27 EP disclosed
WO-1999031263-A1 ALDOL CONDENSATIONS BY CATALYTIC ANTIBODIES THE SCRIPPS RESEARCH INSTITUTE (US) 1999-06-24 WO disclosed